Literature DB >> 33485090

Introduction of a smartphone based behavioral intervention for migraine in the emergency department.

Mia T Minen1, Benjamin W Friedman2, Samrachana Adhikari3, Sarah Corner4, Scott W Powers5, Elizabeth K Seng6, Corita Grudzen7, Richard B Lipton8.   

Abstract

OBJECTIVE: To determine whether a smartphone application (app) with an electronic headache diary and a progressive muscle relaxation (PMR) intervention is feasible and acceptable to people presenting to the Emergency Department (ED) with migraine.
METHODS: This single arm prospective study assessed feasibility by actual use of the app and acceptability by satisfaction with the app. We report preliminary data on change in migraine disability and headache days.
RESULTS: The 51 participants completed PMR sessions on a mean of 13 ± 19 (0,82) days for the 90-day study period, lasting a median of 11 min (IQR 6.5, 17) each. Median number of days of diary use was 34 (IQR 10, 77). Diaries were completed at least twice a week in half of study weeks (337/663). Participants were likely (≥4/5 on a 5-point Likert scale) to recommend both the app (85%) and PMR (91%). MIDAS scores significantly decreased by a mean of 38 points/participant (p < 0.0001). More frequent PMR use was associated with a higher odds of headache free days (p = 0.0148).
CONCLUSION: Smartphone-based PMR introduced to patients who present to the ED for migraine is feasible and acceptable. More frequent users have more headache free days. Future work should focus on intervention engagement.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Engagement; Headache; Healthcare utilization; Progressive muscle relaxation; Recruitment

Mesh:

Year:  2021        PMID: 33485090      PMCID: PMC8721519          DOI: 10.1016/j.genhosppsych.2020.12.009

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  49 in total

1.  The role and interpretation of pilot studies in clinical research.

Authors:  Andrew C Leon; Lori L Davis; Helena C Kraemer
Journal:  J Psychiatr Res       Date:  2010-10-28       Impact factor: 4.791

2.  Costs associated with outpatient, emergency room and inpatient care for migraine in the USA.

Authors:  Ralph P Insinga; Daisy S Ng-Mak; Mary E Hanson
Journal:  Cephalalgia       Date:  2011-10-19       Impact factor: 6.292

3.  An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score.

Authors:  W F Stewart; R B Lipton; J Whyte; A Dowson; K Kolodner; J N Liberman; J Sawyer
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

4.  Migraine prevalence, disease burden, and the need for preventive therapy.

Authors:  R B Lipton; M E Bigal; M Diamond; F Freitag; M L Reed; W F Stewart
Journal:  Neurology       Date:  2007-01-30       Impact factor: 9.910

5.  Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan.

Authors:  Benjamin W Friedman; Clemencia Solorzano; David Esses; Shujun Xia; Michael Hochberg; Niels Dua; Alan Heins; Paul Sasso; Polly E Bijur; Richard B Lipton; E John Gallagher
Journal:  Ann Emerg Med       Date:  2010-03-19       Impact factor: 5.721

6.  Comorbidity of migraine and psychiatric disorders--a national population-based study.

Authors:  Nathalie Jette; Scott Patten; Jeanne Williams; Werner Becker; Samuel Wiebe
Journal:  Headache       Date:  2007-12-07       Impact factor: 5.887

7.  Direct cost burden among insured US employees with migraine.

Authors:  Kevin Hawkins; Sara Wang; Marcia Rupnow
Journal:  Headache       Date:  2007-12-07       Impact factor: 5.887

8.  Biofeedback applications to migraine and tension headaches: a double-blinded outcome study.

Authors:  E J Daly; P A Donn; M J Galliher; J S Zimmerman
Journal:  Biofeedback Self Regul       Date:  1983-03

9.  Smartphone-based migraine behavioral therapy: a single-arm study with assessment of mental health predictors.

Authors:  Mia T Minen; Samrachana Adhikari; Elizabeth K Seng; Thomas Berk; Sarah Jinich; Scott W Powers; Richard B Lipton
Journal:  NPJ Digit Med       Date:  2019-06-04

10.  Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study.

Authors:  Richard B Lipton; Louise Lombard; Dustin D Ruff; John H Krege; Li Shen Loo; Andrew Buchanan; Thomas E Melby; Dawn C Buse
Journal:  J Headache Pain       Date:  2020-02-24       Impact factor: 7.277

View more
  1 in total

1.  Study Design and Protocol of a Randomized Controlled Trial of the Efficacy of a Smartphone-Based Therapy of Migraine (SMARTGEM).

Authors:  Ana Sofia Oliveira Gonçalves; Inga Laumeier; Maxi Dana Hofacker; Bianca Raffaelli; Philipp Burow; Markus A Dahlem; Simon Heintz; Tim Patrick Jürgens; Steffen Naegel; Florian Rimmele; Simon Scholler; Tobias Kurth; Uwe Reuter; Lars Neeb
Journal:  Front Neurol       Date:  2022-06-16       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.